Search results
Smart Money Is Betting Big In MRNA Options - Moderna (NASDAQ:MRNA)
Benzinga· 20 hours agoWhere Is Moderna Standing Right Now? Trading volume stands at 1,451,086, with MRNA's price down by -0.95%, positioned at $110.56. RSI indicators show the ...
Analysts Estimate Moderna (MRNA) to Report a Decline in Earnings: What to Look Out for
Zacks· 6 days agoWall Street expects a year-over-year decline in earnings on lower revenues when Moderna (MRNA Quick QuoteMRNA - Free Report) reports results for the quarter ended March 2024 ...
3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition
InvestorPlace· 18 hours agoBiotech stocks offer the opportunity to invest in life-saving treatments and drugs. If you want to...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...
Recent Insider Activity Suggests Potential Gains for Moderna Inc
Knox Daily· 1 day agoHSBC Securities downgraded its Moderna Inc [MRNA] rating to a Reduce from a a Hold in a research note published on February 26, 2024; the price target was ...
Unveiling Moderna (MRNA) Q1 Outlook: Wall Street Estimates for Key Metrics
Zacks· 2 days agoFree Report) is expected to reveal quarterly loss of $3.59 per share, indicating a decline of 1989.5% compared to the year-ago period. Over the past 30 days, the consensus EPS estimate for the ...
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Zacks· 1 day agoInvestors can't control the latter, but they can focus on a company's earnings results every quarter. This means that investors might want to take advantage of these earnings surprises. Now ...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 5 days agoConsequently, upward revisions in estimates express analysts' positivity towards the company's...
Cerity Partners LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 6 days agoCerity Partners LLC increased its position in shares of Moderna, Inc. (NASDAQ:MRNA – Free Report) by 106.6% during the 4th quarter, according to the company in its most recent ...
Will These 5 Drug/Biotech Stocks Beat Q1 Earnings Forecast?
Zacks via Yahoo Finance· 22 hours agoIts earnings beat estimates in each of the trailing four quarters, delivering an average earnings...